Hexavest’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $8.58M | Buy |
144,934
+29,611
| +26% | +$1.95M | 0.52% | 60 |
|
|
2021
Q2 | $7.71M | Sell |
115,323
-121,209
| -51% | -$7.9M | 0.38% | 90 |
|
|
2021
Q1 | $14.9M | Sell |
236,532
-59,473
| -20% | -$3.7M | 0.66% | 42 |
|
|
2020
Q4 | $18.4M | Sell |
296,005
-117,058
| -28% | -$7.2M | 0.69% | 43 |
|
|
2020
Q3 | $24.9M | Sell |
413,063
-466,343
| -53% | -$28.1M | 0.67% | 45 |
|
|
2020
Q2 | $51.7M | Sell |
879,406
-126,915
| -13% | -$7.59M | 1.2% | 18 |
|
|
2020
Q1 | $56.1M | Sell |
1,006,321
-46,184
| -4% | -$2.82M | 0.98% | 22 |
|
|
2019
Q4 | $67.6M | Buy |
+1,052,505
| New | +$60.3M | 0.82% | 33 |
|
|
2019
Q3 | – | Sell |
-4,930
| Closed | -$224K | – | 513 |
|
|
2019
Q2 | $224K | Hold |
4,930
| – | – | ﹤0.01% | 283 |
|
|
2019
Q1 | $235K | Sell |
4,930
-908,197
| -99% | -$45.2M | ﹤0.01% | 258 |
|
|
2018
Q4 | $47.5M | Sell |
913,127
-891,813
| -49% | -$47.9M | 0.69% | 45 |
|
|
2018
Q3 | $112M | Buy |
1,804,940
+1,011,623
| +128% | +$60M | 1.43% | 14 |
|
|
2018
Q2 | $43.9M | Sell |
793,317
-3,063
| -0.4% | -$165K | 0.57% | 61 |
|
|
2018
Q1 | $50.4M | Sell |
796,380
-733,658
| -48% | -$47.2M | 0.63% | 52 |
|
|
2017
Q4 | $93.8M | Buy |
1,530,038
+33,562
| +2% | +$2.1M | 1.07% | 17 |
|
|
2017
Q3 | $95.4M | Buy |
1,496,476
+33,485
| +2% | +$1.96M | 1.17% | 17 |
|
|
2017
Q2 | $81.5M | Sell |
1,462,991
-61,502
| -4% | -$3.35M | 1.06% | 19 |
|
|
2017
Q1 | $82.9M | Buy |
1,524,493
+51,529
| +3% | +$2.83M | 0.99% | 21 |
|
|
2016
Q4 | $86.1M | Buy |
1,472,964
+790,752
| +116% | +$43.2M | 1.18% | 20 |
|
|
2016
Q3 | $36.8M | Buy |
682,212
+671,584
| +6,319% | +$43.1M | 0.63% | 51 |
|
|
2016
Q2 | $782K | Hold |
10,628
| – | – | 0.01% | 258 |
|
|
2016
Q1 | $679K | Hold |
10,628
| – | – | 0.01% | 258 |
|
|
2015
Q4 | $731K | Hold |
10,628
| – | – | 0.01% | 249 |
|
|
2015
Q3 | $629K | Hold |
10,628
| – | – | 0.01% | 246 |
|
|
2015
Q2 | $707K | Hold |
10,628
| – | – | 0.01% | 253 |
|
|
2015
Q1 | $686K | Hold |
10,628
| – | – | 0.01% | 238 |
|
|
2014
Q4 | $627K | Hold |
10,628
| – | – | 0.01% | 238 |
|
|
2014
Q3 | $544K | Hold |
10,628
| – | – | 0.01% | 253 |
|
|
2014
Q2 | $516K | Hold |
10,628
| – | – | 0.01% | 254 |
|
|
2014
Q1 | $552K | Hold |
10,628
| – | – | 0.01% | 248 |
|
|
2013
Q4 | $565K | Sell |
10,628
-546,845
| -98% | -$27.9M | 0.01% | 261 |
|
|
2013
Q3 | $25.8M | Sell |
557,473
-15,076
| -3% | -$662K | 0.39% | 79 |
|
|
2013
Q2 | $25.6M | Buy |
+572,549
| New | +$24.9M | 0.44% | 67 |
|
Other funds holding BMY
Hexavest's BMY Position: Q3 2021 in Review
Hexavest increased its Bristol-Myers Squibb (BMY) stake by 26% in Q3 2021, buying an estimated $1.95M and bringing the position to 144,934 shares worth $8.58M. The position accounts for 0.52% of the portfolio, ranked #60.
Hexavest first reported a position in BMY in Q2 2013 and has held it in 33 quarters since. The position peaked at $112M in Q3 2018. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Hexavest held 144,934 shares of Bristol-Myers Squibb worth $8.58M as of Q3 2021.
- Hexavest bought 29,611 Bristol-Myers Squibb shares in Q3 2021, an estimated $1.95M.
- Bristol-Myers Squibb made up 0.52% of Hexavest's portfolio in Q3 2021, its #60 holding.
- Hexavest first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 33 quarters since.
- Hexavest's Bristol-Myers Squibb position peaked at $112M in Q3 2018.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.